119 related articles for article (PubMed ID: 37633945)
1. SPDEF enhances cancer stem cell-like properties and tumorigenesis through directly promoting GALNT7 transcription in luminal breast cancer.
Li J; Wan X; Xie D; Yuan H; Pei Q; Luo Y; Chen Y; Xian J; Ye T
Cell Death Dis; 2023 Aug; 14(8):569. PubMed ID: 37633945
[TBL] [Abstract][Full Text] [Related]
2. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.
Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923
[TBL] [Abstract][Full Text] [Related]
3. The subtype-specific molecular function of SPDEF in breast cancer and insights into prognostic significance.
Ye T; Li J; Feng J; Guo J; Wan X; Xie D; Liu J
J Cell Mol Med; 2021 Aug; 25(15):7307-7320. PubMed ID: 34191390
[TBL] [Abstract][Full Text] [Related]
4. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
Cheng XH; Black M; Ustiyan V; Le T; Fulford L; Sridharan A; Medvedovic M; Kalinichenko VV; Whitsett JA; Kalin TV
PLoS Genet; 2014 Sep; 10(9):e1004656. PubMed ID: 25254494
[TBL] [Abstract][Full Text] [Related]
5. SPDEF suppresses head and neck squamous cell carcinoma progression by transcriptionally activating NR4A1.
Wang Y; Ren X; Li W; Cao R; Liu S; Jiang L; Cheng B; Xia J
Int J Oral Sci; 2021 Oct; 13(1):33. PubMed ID: 34667150
[TBL] [Abstract][Full Text] [Related]
6. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
[No Abstract] [Full Text] [Related]
7. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
[TBL] [Abstract][Full Text] [Related]
8. GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma.
Nie GH; Luo L; Duan HF; Li XQ; Yin MJ; Li Z; Zhang W
Tumour Biol; 2016 Apr; 37(4):4559-67. PubMed ID: 26503214
[TBL] [Abstract][Full Text] [Related]
9. Double Agent:
Ye T; Feng J; Wan X; Xie D; Liu J
Cancer Manag Res; 2020; 12():3891-3902. PubMed ID: 32547225
[TBL] [Abstract][Full Text] [Related]
10. The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.
Wang X; Xing L; Yang R; Chen H; Wang M; Jiang R; Zhang L; Chen J
Mol Cancer; 2021 Jun; 20(1):91. PubMed ID: 34116677
[TBL] [Abstract][Full Text] [Related]
11. H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.
Xie N; Zhang R; Bi Z; Ren W; You K; Hu H; Xu Y; Yao H
Cell Oncol (Dordr); 2023 Apr; 46(2):375-390. PubMed ID: 36576700
[TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA FOXD2‑AS1/miR‑150‑5p/PFN2 axis regulates breast cancer malignancy and tumorigenesis.
Jiang M; Qiu N; Xia H; Liang H; Li H; Ao X
Int J Oncol; 2019 Mar; 54(3):1043-1052. PubMed ID: 30628646
[TBL] [Abstract][Full Text] [Related]
13. FAM84B promotes breast cancer tumorigenesis through activation of the NF-κB and death receptor signaling pathways.
Zhang Y; Yang F
Pathol Res Pract; 2023 Sep; 249():154785. PubMed ID: 37651838
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells.
Pal M; Koul S; Koul HK
J Biol Chem; 2013 Apr; 288(17):12222-31. PubMed ID: 23449978
[TBL] [Abstract][Full Text] [Related]
15. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer.
Xie D; Chen Y; Wan X; Li J; Pei Q; Luo Y; Liu J; Ye T
Front Endocrinol (Lausanne); 2022; 13():916469. PubMed ID: 35784532
[TBL] [Abstract][Full Text] [Related]
16. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1.
Wu J; Qin W; Wang Y; Sadik A; Liu J; Wang Y; Song P; Wang X; Sun K; Zeng J; Wang L
J Cell Biochem; 2018 Nov; 119(11):9042-9054. PubMed ID: 30076647
[TBL] [Abstract][Full Text] [Related]
17. GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration.
Tamura RE; Paccez JD; Duncan KC; Morale MG; Simabuco FM; Dillon S; Correa RG; Gu X; Libermann TA; Zerbini LF
Oncotarget; 2016 Mar; 7(12):13865-79. PubMed ID: 26885618
[TBL] [Abstract][Full Text] [Related]
18. The role of SPDEF in cancer: promoter or suppressor.
Bao KC; Wang FF
Neoplasma; 2022 Dec; 69(6):1270-1276. PubMed ID: 35951453
[TBL] [Abstract][Full Text] [Related]
19. The circRNA circ_0000291 acts as a sponge of microRNA 326 to regulate E26 transformation-specific sequence-1 expression and promote breast cancer progression.
Min J; Pan X; Lv G
Pathol Int; 2020 Dec; 70(12):953-964. PubMed ID: 32869935
[TBL] [Abstract][Full Text] [Related]
20. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
